DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors
Moritz N. Wente, Jörg Kleeff, Markus W. Büchler, Jantien Wanders, Peter Cheverton, Stephen Langman, Helmut FriessVolume:
23
Language:
english
Pages:
9
DOI:
10.1007/s10637-005-1442-2
Date:
August, 2005
File:
PDF, 436 KB
english, 2005